Frontiers in Cardiovascular Medicine (Apr 2021)

Heart Transplantation in Mustard Patients Bridged With Continuous Flow Systemic Ventricular Assist Device - A Case Report and Review of Literature

  • Rody G. Bou Chaaya,
  • Joel W. Simon,
  • Mark Turrentine,
  • Jeremy L. Herrmann,
  • William Aaron Kay,
  • Maya Guglin,
  • Kashif Saleem,
  • Roopa A. Rao

DOI
https://doi.org/10.3389/fcvm.2021.651496
Journal volume & issue
Vol. 8

Abstract

Read online

Thirty four-year-old male with history of D-transposition of the great arteries (D-TGA) who underwent Mustard operation at 14 months of age presented in cardiogenic shock secondary to severe systemic right ventricular failure. Catheterization revealed significantly increased pulmonary pressures. Due to the patient's inotrope dependence and prohibitive pulmonary hypertension, he underwent implantation of a Heart Ware HVAD® for systemic RV support. Within 4 months of continuous flow ventricular assist device (VAD) implantation complete normalization of pulmonary vascular resistance (PVR) was achieved. He ultimately underwent orthotopic heart transplantation with favorable outcomes. This is the second report of complete normalization of PVR following VAD implantation into a systemic RV in <4 months. We conducted a thorough literature review to identify Mustard patients that received systemic RV VAD as a bridge to a successful heart transplantation. In this article, we summarize the outcomes and focus on pulmonary hypertension reversibility following VAD implant.

Keywords